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The process of stimulating small, resting T  lymphocytes to proliferate is accompa- 
nied by the appearance of new cell surface antigens. These antigens, characterized as 
T  cell activation antigens by their presence on  activated T  cells and  their absence 
from  resting  T  cells, are  not  necessarily T  cell  specific.  Some,  like the  transferrin 
receptor (1-6), the insulin receptor (7), and the 4F2 antigen (8), have a broad cellular 
distribution  and  are  present  on  proliferating cells  of many  types.  The  HLA-DR 
antigen, which appears on T  cells after activation (9-13), is not restricted to cells of 
the  immune  system  but  nevertheless  plays a  critical role  in  the  regulation  of the 
immune response. At present, only one T  cell activation antigen, Tac  (14), has been 
found solely on activated T  cells. 
We have used monoclonal antibodies (mAb) 1 against seven different molecularly 
defined T  cell activation antigens to explore the order of events following mitogen- 
dependent  activation.  Immunofluorescence  in  combination  with  the  simultaneous 
analysis of DNA content has allowed the classification of activation antigens according 
to the kinetics of their appearance and the degree to which they are associated with 
proliferating cells. 
Materials  and  Methods 
MAb.  MAb  OKTllA,  OKT10  (4,  15),  and  OKT9  (3,  6)  were  the  gift of Dr.  Gideon 
Goldstein (Ortho Pharmaceutical, Raritan, NJ). MAb 5E9 (3) and 4F2 (8) were from Dr. Bart 
Haynes (Duke University, Durham, NC). MAb B1 49.9 (49.9) and B1  192 (19.9) were the gifts 
of Dr. Bernard Malissen and Dr. Claude Mawas (University of Monseilles, Marseilles, France). 
The  anti-Tac Ab was  the  generous gift of Dr.  Thomas  Waldmann  (National Institutes of 
Health,  Bethesda,  MD).  The  monoclonal anti-HLA-DR Ab was purchased  from  Bethesda 
Research Laboratories (Rockville, MD). OKT 11A recognizes 100% of thymocytes and 100% of 
peripheral blood lymphocytes that rosette with sheep erythrocytes and is thought to be directed 
against the E rosette receptor on lymphocytes. The other Ab recognize cell surface proteins that 
* Supported by a fellowship from the Jane Coffin Childs Memorial Fund for Medical Research. Present 
address: Department  of Pediatrics and Genetics, University of Washington  School of Medicine, Seattle, 
WA 98195. 
:~ Supported by grant AM 21094 from the National Institutes of Health. 
§ Supported by grant AI 15669 from the National Institutes of Health. 
a Abbreviations used in this paper: Ab, antibody; E+~ rosetting blood mononuclear  cells; E-, nonrosetting 
blood mononuclear cells; FITC-RaMIg, fluoresceinated (Fab')2 of Ab to mouse immunoglobulin;  HO342, 
DNA dye Hoechst 33342; IL-2, interleukin 2; mAb, monoclonal antibody; PHA, phytohemagglutinin-P. 
J. ExP. MEn. © The Rockefeller University Press • 0022-1007/83/02/0461 / 12 $1.00  461 
Volume 157  February 1983  461-472 462  HUMAN T  CELL ACTIVATION ANTIGEN EXPRESSION 
appear  on T  cells after lectin-induced stimulation.  5E9 and  OKT9 recognize the transferrin 
receptor  (3,  6).  OKT10 recognizes a  46,000-mol  wt antigen  (3,  15),  whereas the anti-Tac Ab 
recognizes a  protein that  appears  to be restricted to activated T  cells (14).  Ab  19.2 recognizes 
a 240,000-dahon  component, whereas 49.9 recognizes a 55,000-dahon  protein on the surface of 
activated T  cells (16). 
Cell Preparation.  Peripheral  blood  mononuclear  leukocytes  were  obtained  from  normal 
human volunteers by Ficoll-Hypaque density gradient centrifugation of defibrinated blood. A 
population  enriched  for T  cells was obtained  by rosetting with  neuraminidase-treated  sheep 
erythrocytes. The resulting rosetting (E  ÷) and nonrosetting (E-) cells were incubated separately 
in  100-mm plastic petri dishes in 8% fetal calf serum at a concentration of 2-5 ×  106/ml. The 
adherent  E- cells were recovered with a  rubber  policeman after removing nonadherent  cells 
with three  media washes.  The  E--adherent  cells were counted  and  placed  in  a  75-cm  2 flask 
(Falcon Labware, Oxnard, CA) together with the nonadherent  E + cells in a  ratio of 1:25  (E- 
adherent/E + nonadherent). 
Lectin Stimulation.  T  cell-enriched lymphocytes were placed in bulk culture in 75-cm  2 flasks 
at a  concentration of 1-2 X  106/ml in RPMI  1640 medium with penicillin and streptomycin 
and supplemented with 8% fetal calf serum. Flasks received either 2 #g/ml phytohemagglutinin- 
P  (PHA)  (Difco Laboratories,  Detroit,  MI)  and  10 ~g/ml conconavalin  A  (Sigma Chemical 
Co., St. Louis, MO)  or medium alone. The cultures were incubated  at  37°C in a  humidified 
atmosphere of 5% CO2 in air. Aliquots containing ~1-2  ×  10  7 cells were removed at various 
times for analysis of cell surface antigens. 
Staining Procedures.  Cultured cells were washed once in warm medium with special attention 
given to  dispersing  clumped  cells after  both  centrifugations.  The  DNA  dye  Hoechst  33342 
(HO342)  (Hoechst AG, Frankfurt,  Federal Republic of Germany)  was added  from a  100-/~M 
solution to  106 cells/ml in RPMI  1640 to a  final concentration of 5/~M. At 5/LM, HO342 has 
previously been shown to be a  stoichiometric stain for DNA (17,  18).  Cells were incubated  at 
37°C for 45-60 rain. The cells were pelleted, washed twice in ice cold medium, and resuspended 
to a  concentration  of 107 cells/ml in medium with 0.2%  soybean  trypsin  inhibitor as carrier 
protein.  50  /~l  of cells  (or  5  X  105  cells)  was  added  per  well  to  a  96-well  round-bottomed 
microtiter plate (Dynatech Laboratories, Inc., Alexandria, VA) and incubated with either mAb 
(freshly centrifuged at  100,000 g  for 30 min)  or purified normal  mouse IgG. After  1 h  on ice, 
cells were washed three times and incubated for an additional hour with 25/~1 ofa 1:20 dilution 
of the fluorescein-conjugated F(ab')2 fragment of rabbit anti-mouse IgG (FITC-RaMIg)  (N. L. 
Cappel Laboratories Inc., Cochranville, PA). Cells were washed four times and maintained at 
0-4°C until flow cytometric analysis. 
Flow Cytometry.  The dual illumination beam instrument has been described (19, 20). Briefly, 
the blue fluorescence of HO342 was excited by ultraviolet light (350  370 nm)  from a  mercury 
arc lamp;  the emitted  fluorescence was  detected  by a  photomultiplier  fitted  with  a  420-nm 
long-pass filter and a  450-nm broad-band  interference filter. The green fluorescence (530-570 
nm)  of fluorescein  was  excited  by  the 488-nm  beam  of an  argon  ion  laser.  Two-parameter 
distributions  were accumulated  using  a  hardwired  analyzer  incorporating  a  storage  display 
oscilloscope. Windows on the display were set such that  <3% of the cells stained  with FITC- 
RaMIg  alone  were  positive.  Except  for  the  OKTllA  staining,  which  served  as  a  positive 
control, the percentage of total lectin-stimulated cells staining with a given Ab was determined 
by subtraction  of the percentage of stained cells from cultures that  received no lectin. At least 
10,000  cells were analyzed for determination of the percentage of immunofluorescence-positive 
cells as well as their cell cycle position. Pictures represent  1,000  cells (each white dot represents 
one cell). 
Results 
Temporal Appearance of Activation Antigens on Mitogen-stimulated T Cells.  One potential 
means  of gaining  insight  into  an  activation  antigen's  function  is  to  determine  the 
kinetics  of its appearance  and  to  compare  this with  the  acquisition  of functional  T 
cell activities. It was  therefore of interest  to see whether activation antigens  could be 
distinguished  and  classified on the basis of the rate of appearance  after activation of resting T  cells. Peripheral blood T  cells, prepared by rosetting with sheep erythrocytes, 
were stimulated with PHA and examined at  various times for their reactivity with 
each of seven mAbs to previously defined T  cell activation antigens. 
The results of eight separate experiments, summarized in Fig.  1, showed that each 
antigen  was present  initially on <6%  of resting T  cells.  Lymphocyte activation by 
PHA evoked the appearance of four antigens within the first 24 h. The 4F2 antigen, 
Tac, the 49.9 antigen, and the transferrin receptor appeared on an average of 21-55% 
stimulated  cells within  24 h.  By contrast,  both  the HLA-DR antigen  and  the  19.2 
antigen did not appear until much later and were not found on > 10% of stimulated 
cells until 72 h. The kinetics of the expression of the OKT 10 antigen were intermediate 
in nature, being found on an average of 12% of cells at 24 h  and increased gradually 
to an average of almost 50% at 96 h. These results indicated that each of the activation 
antigens  had  a  characteristic  and  reproducible  time  of  appearance  after  T  cell 
activation by mitogens. 
To investigate whether the four earliest antigens could be further distinguished, an 
earlier  time course was performed.  One such experiment  is shown  in  Fig.  2 a. The 
4F2 antigen was the first antigen to appear, as it was detectable within 4 h  of PHA 
addition (Fig. 2). The 4F2 antigen expression increased continuously and progressively 
with  time both with  respect  to the  number of 4F2 + cells and  the intensity of 4F2 
antigen expression. The transferrin receptor appeared within the first 4-8 h  (Fig. 2 b), 
whereas Tac expression was first distinguishable from background at 8 h, and by 16 
h  a  marked shift in antigen intensity was evident. The 49.9 antigen was marginally 
detectable at 8 h  and became readily apparent at  16 h. Thus, the four antigens that 
appear earliest upon activation could further be ordered when a finer time course was 
carried  out.  Other  experiments  showed  that  the  absolute  times when  a  particular 
antigen  became  accessible  varied  slightly  from  experiment  to  experiment  but  the 
relative order remained  the same:  4F2  was the earliest,  followed by the transferrin 
receptor, and finally Tac and the 49.9 antigen. 
The 4F2 Antigen,  Tac, the 49.9 Antigen, and the Transferrin Receptor Appear before DNA 
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FzG.  1.  Time course of appearance of T  cell activation antigens. A summary of eight activation 
experiments shows the average reactivity of seven monoclonal Abs on T  cells (E  +) stimulated at 2 
X  106/ml with 2/.tg/ml PHA.  1,000 cells were analyzed per sample and values presented are those 
after subtracting control values, incubated without PHA for the corresponding times. 
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Fro.  2.  Temporal appearance  of the four earliest-activation antigens.  Bulk T  cell cultures were 
initiated as in Fig. 1 at 24, 16, 8, 4, and 0 h before harvesting. Cells were divided into six parts and 
analyzed  for reactivity with  (a) 4F2, (b) 5E9 and OKT9, (c) anti-Tac, (d) 49.9, and nmIg and 
OKTll  (not shown). Reactivity  with  nmIgG  was <3%  and reactivity  with  OKTll  was ~95% 
during the course of the experiment. 
Synthesis.  The very early kinetics of the 4F2 antigen, Tac, the 49.9 antigen, and the 
transferrin  receptor  seemed  to  indicate  that  these  antigens  appeared  on  mitogen- 
stimulated cells before DNA  synthesis.  To  examine  this  question,  we  used  the  dye 
HO342,  which stains DNA stoichiometrically, to analyze individual cells simultane- 
ously for DNA content  and  immunofluorescence  (20).  T  cells were stimulated with 
PHA and at various times cells were removed and incubated for 45 min at 37°C with 
5/~M  HO342  and then cells were reacted with Ab and analyzed by flow cytometry. 
The  results  of a  typical experiment  clearly indicate  that  all  four  antigens  appear 
before  any  increase  in  DNA  content  (Figs.  3C-F).  The  four  antigens  were  found 
on  20-50%  of PHA-treated  T  cells  at  24  h,  at  which  time  there  was  no  marked 
increase in the percentage of cells in the S, Gz, and M  cell cycle compartments (1.1%) 
over the control of cells cultured without  PHA for 24 h  (1.2%). 
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FIG. 3.  Four T cell activation antigens appear before DNA synthesis. T cells were stimulated with 
PHA as before and analyzed simultaneously for immunofluorescence and DNA content at 24 h. (A) 
Histogram key. Cells were stained with (B) nmIgG, ((3) 4F2, (D) 5E9, (E) a-Tat, and (F) 49.9. Cells 
appearing in the S, G2, and M window in the right panel of C are clumped (see text). Immunoflu- 
orescent windows are fixed such that reactivity with FITC-RaMIg was <3% and windows for DNA 
content  were set by comparison with Hoechst fluorescence patterns of either mitogen-stimulated 
cultures 72 h or older, or long-term IL-2 T cells of normal karyotype. 
and  DNA  content  after activation  is shown  in  Fig. 4.  When  analyzed at  24  h,  the 
transferrin receptor, the 4F2 antigen, the 49.9 antigen, and Tac showed a  net increase 
of from  22  to 53%, whereas the percentage of cells in S, (32, or M  stages of the cell 
cycle had  increased <1%.  Because  these four antigens appeared before any cellular 
proliferation, it is clear that the increase in antigen expression occurred in cells having 
undetectable amounts  of these antigens at  the cell surface.  The increase in antigen 
expression was not due to the expansion of a  small percentage of 4F2  +, Tac  +, 49.9  +, 
and  transferrin  receptor-bearing  cells  present  before  activation.  This  result  is  in 
confirmation of previous results reported for Tac  (14)  and the 4F2 antigen  (8). The 
term  "early" proteins is used  to describe those  viral proteins in  virus-infected cells 
that are made before replication of viral DNA. We have adopted this terminology to 
the T  cell activation antigens and will refer to the 4F2 antigen, Tac, the 49.9 antigen, 
and the transferrin receptor as early antigens. 
Growth Association of the Early Antigens.  Because  Tac,  the  4F2  antigen,  the  49.9 
antigen,  and  the  transferrin  receptor  appeared  before  DNA  synthesis,  we  next 
investigated the possibility that one of these markers could be used  to predict later 
cellular events such as DNA synthetic capacity and cellular proliferation. Therefore, 
we examined  that  fraction of cells appearing in  the proliferative phases  of the cell 466  HUMAN T  CELL ACTIVATION ANTIGEN EXPRESSION 
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FI~.  4.  The  transferrin  receptor,  Tac,  the  4F2  antigen,  and  the  49.9  antigen  are  early T  cell 
activation antigens. The histogram summarizes nine separate experiments at 24 h. The background 
immunofluorescence staining was analyzed on  resting T  cells  (no  PHA)  (stippled  bars)  and the 
highest background (10%)  was associated with the 4F2 mAb. DNA synthesis had not begun at the 
time of staining, there was only ~ 1% more S, Ge, or M  phase cells in the PHA-stimulated cultures 
(clear bar vs. darkened bar), However, a striking increase in expression of all four early antigens was 
demonstrated by PHA-stimulated T  cells (cross-hatched bars). 
cycle (i.e.,  S,  G2, or M)  that expressed these early-activation antigens.  When  PHA- 
stimulated  cells were examined  at day 3--a time when  a  large fraction of the cells 
were in S, G2, or M--a striking result was obtained. Over 90% of the activated T  cells 
that  were in S, G2, or M  were expressing each of the four early-activation antigens 
(Table 1, Fig. 5 B-E). Representative pictures demonstrate that 72 h after the addition 
of PHA there is a  dramatic shift in both expression of the early-activation antigens 
(vertical axis)  and the number of cells in the proliferative compartments of the cell 
cycle (horizontal axis). By focusing on just those cells in S, Gz, or M  (those to the right 
of the medial vertical line), it is apparent that although they fail to react with normal 
mouse IgG (Fig.  5 A, right panel), >95%  manifest a  strong reactivity with 4F2  and 
Tac  (right  panels  of Fig.  5B  and E)  and 90%  react with 49,9  and  antibody to the 
transferrin receptor (right panels of Fig. 5 C and D). Because virtually every cell found 
in  the  S,  G2,  or  M  phase  of the  cell  cycle  expresses  each  of the  early-activation 
antigens,  it  indicates  that  before DNA synthesis occurs  in  T  cells they will  express 
each of these antigens. 
The degree to which cells in S, G2, or M  express Tac and the 49.9 antigen, which 
to date have only been found on activated T  cells, depends on the purity of T  cells in 
the culture. It is possible that the 5-10% subpopulation of cells in S, Gz, or M  that fail 
to  express  these  antigens  represent  contamination  by proliferating  non-T  cells.  A 
second difficulty that must be overcome is clumping of cells. Cells clumped as doublets 
will appear in the S, G2, or M  window at the tetraploid  (4C) position. Clumped cells 
can be monitored  and  distinguished  in  three ways.  First,  clumping is random  and 
appears in triplets, and quadruplicates  will also appear at the 6C and 8C positions. COTNER  ET AL. 
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Fto.  5.  The expression of the four early T  cell activation antigens  on cells in the proliferative 
phase of the cell cycle. T cells were stimulated with PHA as before and analyzed at 72 h as in Fig. 
3. Pictures were chosen to most closely approximate average values (see Table I). (A) nmlgG, (B) 
4F2, (C) 5E9, (D) 49.9, (E) a-Tac. S, G2, and M phase cells are to the right of the central vertical 
white line, and the majority of cycling cells are immunofluorescence positive (above horizontal line). 
Many G0/G1 phase cells (left of vertical bar) are also immunofluorescence positive. 
Second, DNA synthesis is continuous and cells in the S  phase produce a  continuous 
pattern.  In  cultures  exhibiting  zero  to  moderate  proliferation,  cells  clumped  as 
doublets appear discontinuous, with a  disproportionately low fraction of cells inter- 
mediate  between  the diploid and  tetraploid clusters.  Finally, multiple samples are 
always analyzed from the same culture and contain the same proportion of cells in 
the S, G2, or M  window so that the presence of clumps in any one sample is discernible. 
T Cell Proliferation Is Initially Independent of the Expression of HLA-DR,  7/0, and the 19.2 
Antigens.  There are several reports that  the appearance of HLA-DR  is a  relatively 
late occurrence after mitogen-dependent activation of T  cells (11,  13, 21).  However, 
it  remains  uncertain  whether  T  cells must  express  HLA-DR  before  proliferating. 
Hence,  it  was  of interest  to  determine  what  percentage  of proliferating cells bore 
HLA-DR.  Cellular proliferation was  measured  by estimating the  DNA  content  of 
individual cells and determining the percentage of cells in the S, G2, and M  phases of 
the cell cycle. Only populations having at least 10% of the cells in S, G2, and M  were 
analyzed further for HLA-DR  expression. As shown in Table I, when only those cells 
that had entered the proliferative phase of the cell cycle were analyzed, only ~20% of 
these were HLA-DR +.  Because we have seen no cell cycle-specific changes in HLA- 
DR expression (data not shown), we conclude that the ability of T  cells to proliferate 
in a  mitogen-dependent system is apparently independent of T  cell HLA-DR  expres- 468  HUMAN T  CELL ACTIVATION ANTIGEN  EXPRESSION 
TABLE  I 
Expression of Activation Antigens on Dividing Cells 
Percent immunoflu-  Number of 
Ab  experiments  orescent  cells in  Range 
S, G2, and M 
4F2  12  94.8 + 5.2  83-100 
5E9  13  89.6 + 7.9  79-100 
499  9  90.1 _ 4.8  80-97 
~-Tac  8  95.9 ± 4.6  90-100 
HLA-DR  11  18.3 +  12.0  3-37 
T10  8  54.5 ± 20.2  24-83 
192  6  33.4 ±  11.1  17-47 
sion. Similar conclusions have been reached by others (22) who have failed to inhibit 
mitogen-dependent  T  cell  proliferation  with  Abs to HLA-DR.  Similarly,  there  is  a 
lack of association  between  proliferating  cells  and  the  expression  of the T10 or the 
19.2 antigens, as T10 was found on 55% and  19.2 on 33% of cells in S, G2, or M  stages 
of the cell cycle. Thus, both HLA-DR and antigen  19.2 are expressed on the average 
after DNA synthesis and may be classified as "late" antigens, whereas the T10 antigen 
is intermediate both in its temporal appearance and the degree to which it is associated 
with dividing cells. Although expression of these late antigens is not a  prerequisite of 
cellular proliferation for the majority of T  cells, our data do not permit us to rule out 
the possibility that their expression is necessary for the proliferation ofa subpopulation 
of T  cells. 
Discussion 
This study demonstrates that of the seven T  cell activation antigens examined here, 
four are expressed at the surface of activated T  cells before the onset of DNA synthesis. 
These  four proteins,  called  early-activation  antigens,  were  the  transferrin  receptor, 
the T  cell activation antigen Tac, and two antigens recognized by the mAb 4F2 and 
49.9.  This  finding  is  similar  to  the  previously reported  early  expression  of insulin- 
binding sites on activated lymphocytes (7) and confirms the result of Uchiyama et al. 
(14)  that Tac is expressed before DNA synthesis. A  second, unanticipated  result was 
that these same four early antigens are found on virtually all T  cells by the time they 
reach the S phase of the cell cycle. Thus, when just the cells in the S, G2, or M  stages 
of the cell cycle were examined, an average of 90-96% of these cells expressed each of 
the four early antigens. The fact that essentially all S, G~, or M  cells were 4F2 +, 49.9 +, 
Tac  +, or 5E9/OKT9 + was not due to an overlap from the increased HO342 fluores- 
cence because  (a)  the effect seen was specific for the early antigens  and was not seen 
for the three later-appearing antigens  (see Table I) and (b) excitation and emission of 
HO342 and FITC occurred independently as the cell passed two separate beams,  (c) 
immunofluorescence  results  were  unchanged  when  HO342  was  deleted  from  the 
staining protocol (not shown). 
The fact  that  each early activation  antigen  is expressed  before the onset  of DNA 
synthesis  suggests  that  subsequent  cell  cycle progression  does  not  occur before  the 
function of each  of these  early antigens  has  been  executed.  Although  a  cell-surface 
protein whose function was required  for T  cell growth would be expected to appear 
on all T  cells before their entering the proliferative phase of the cell cycle, our data do COTNER  ET AL.  469 
not establish an obligatory role for these proteins in promoting cell growth. However, 
the fact that these antigens are induced to appear on activated T  cells and are present 
on essentially all T  cells before the initiation of DNA synthesis marks these proteins 
as  excellent  candidates  for molecules causally  related  to  cell  growth.  One  general 
approach that might establish a causal link between expression of the early activation 
antigens and subsequent events in the cell cycle is to see what the effect of inhibiting 
the function of the activation antigen has on cell growth. Abrogation of the antigen 
function can be achieved by blocking with antibody to the antigen, or in the case of 
an antigen that is a  known receptor, by depriving the appropriate ligand.  Recently 
there  have  been  reports  that  Ab  to  each  of  the  four  early-activation  antigens 
reproducibly but not completely block T  cell proliferation  (5,  23), whereas OKT10, 
AB19.2, and Ab to HLA-DR do not  (T. Corner, unpublished observations; 22). The 
failure to achieve complete inhibition may result from the fact that a given mAb sees 
such a restricted site on its target antigen that it may not completely compromise the 
function of that  molecule. For instance,  four mAb to the transferrin  receptor  (5E9, 
OKTg,  B3/25,  CP200)  fail  to  block  the  binding  of transferrin  (3,  4;  T.  Cotner, 
unpublished observations), and the only instance in which a mAb successfully blocks 
transferrin binding was achieved by specifically selecting Ab for that property (24). 
It is interesting to correlate what  is known about the role of the early activation 
antigens with what  is known about the growth-promoting activity of their ligands. 
Sato and his co-workers (reviewed in 25)  have defined serum-free media for a number 
of cell lines  and this  has led  to the conclusion  that  transferrin  (or lactoferrin)  is a 
universal  requirement  for the  long-term  growth  of all  mammalian cell  types.  The 
requirement  for insulin,  whose receptor is  an early-activation antigen  (7),  is  not  as 
stringent, but  it, too, is a  component of all defined media. Of special interest  is the 
fact that both transferrin and insulin are components of defined media that support 
the growth of B  cells  (26)  and T  cells responding in mixed leukocyte reactions  (27, 
28). Finally, there is now a considerable body of evidence that interleukin 2 (IL-2) is 
required  to  support  T  cell  proliferation  (29,  30;  for reviews see  31,  32).  The  IL-2 
receptor  itself is  an  activation  antigen  that  appears  rapidly  (4-8  h  [33,  34]  after 
mitogen  activation)  and  would  be  expected  to  have  the  same  growth-association 
property exhibited  by the transferrin  receptor and  the  three other early-activation 
antigens studied here. In examining the cellular distributions of the IL-2 receptor and 
the early-activation antigens, it was apparent that both Tac and the 49.9 antigen, but 
not the 4F2 antigen, had cell distributions congruent with that of the IL-2 receptor, 
i.e., present on all IL-2-dependent cells and lines but absent from T  and B lympho- 
blastoid  cell  lines.  The IL-2 receptor had  previously been  shown  to be present  on 
three lines derived from cutaneous T  cell lymphomas (35)  that are not dependent on 
exogenous IL-2. We have examined two of these, HUT-78 and HUT-102, and both 
Tac  and  the  49.9  antigen  are  strongly  expressed  on  HUT-102  and  detectable  on 
HUT-78. Recently, we have learned that at least a Tac recognizes the IL-2 receptor 
because it competes with IL-2 for binding to IL-2-dependent cells (36).  The supposi- 
tion that there is a causal link between expression of the early activation antigens and 
cell growth is based on their absolute expression on growing cells and the ability of 
Ab to these antigens to inhibit, albeit incompletely, T  cell proliferation. Until Ab are 
produced  that  are  more effective in  blocking T  cell  growth,  this  hypothesis  relies 
heavily on the previously demonstrated  growth-promoting activity of their ligands, 470  HUMAN T  CELL ACTIVATION ANTIGEN  EXPRESSION 
transferrin,  IL-2,  and  insulin.  Regardless  of what  the  functional  activities  of the 
remaining early-activation  antigens  turn out  to be,  it  seems reasonable  to speculate 
that their functions will be important in influencing G1 transit and the stimulation of 
DNA synthesis. 
Summary 
Cell-surface antigens that are induced to appear on T  cells activated by the lectin 
phytohemagglutinin-P  (PHA)  can  be classified  both  on  the  basis  of the  kinetics  of 
their  appearance  and  on  their  growth-association  properties.  Seven  distinct  T  cell 
activation  antigens,  defined  by  monoclonal  antibodies,  were  classified  as  early, 
intermediate,  or late antigens  based  on their  temporal  appearance  relative  to DNA 
synthesis.  Four antigens,  the transferrin  receptor,  the T  cell  activation antigen  Tac, 
the  4F2  antigen,  and  the  49.9  antigen  were  early  antigens,  whereas  the  OKT10 
antigen appeared at intermediate times and both HLA-DR and antigen 19.2 appeared 
late. The use of a  dye, Hoechst 33342, which stains DNA stoichiometrically, allowed 
the simultaneous analysis of immunofluorescence and cell cycle position of individual 
cells. This analysis unexpectedly revealed that essentially all cells in the proliferative 
phase  of the  cell  cycle  expressed  each  of the  four  early-activation  antigens.  The 
correlation  between  expression  of  the  four  early-activation  antigens  and  T  cell 
proliferation suggests that these molecules are important for the growth of all T  cells. 
The relationship  of two of these activation  antigens,  known to be the  receptors  for 
transferrin and interleukin 2, a T  cell growth factor, is discussed with special reference 
to the roles of their ligands in supporting the growth of T  cells. 
We thank Gideon Goldstein, Bart Haynes, Bernard Malissen, and Claude Mawas for generously 
supplying antibodies and Thomas Waldmann for providing anti-Tac and for informing us of 
results  in advance of publication.  We also thank Martin  Hemler and Carl Ware for critical 
review of the manuscript and Joyce Culgin for excellent  clerical assistance. 
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